Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 55, Issue 1, 2003, Pages 85-91

  Koester, Letícia S ^a   Xavier, Clarissa R ^a   Mayorga, Paulo ^a   Bassani, Valquiria L ^a,b  

^a Programa de Pos graduacao em C F   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Carbamazepine; Complexes; Freeze drying; Hydroxypropyl methylcellulose; In vitro dissolution; Matrix tablets; Spray drying; Cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; CARBAMAZEPINE; HYDROXYPROPYLMETHYLCELLULOSE; METHOCEL K100LV;

ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; FREEZE DRYING; GELATION; HYDROPHILICITY; IN VITRO STUDY; MATRIX TABLET; SOLID; SPRAY DRYING; TABLET FORMULATION;

EID: 0037242499     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(02)00127-3     Document Type: Article

References (19)

1. Bibby D.C., Davies N.M., Tucker I.G. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 197:2000;1-11.
2. 7M-β-cyclodextrin as a solubilizing agent. J. Pharm. Sci. 90:2001;807-816.
3. Sangalli M.E., Zema L., Maroni A., Foppoli A., Giordano F., Gazzaniga A. Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials. 22:2001;2647-2651.
4. Kinalekar M.S., Kulkarni S.R., Vavia P.R. Simultaneous determination of α-, β- and γ-cyclodextrins by LC. J. Pharm. Biopharm. Anal. 22:2000;661-666.
5. Bielejewska A., Kozbial M., Nowakowski R., Duszczyk K., Sybilska D. Studies on the behaviour of α-, β- and γ-cyclodextrins and some derivatives under reversed-phase liquid chromatographic conditions. Anal. Chim. Acta. 300:1995;201-206.
6. Levy R., Wilensky A.J., Anderson G.D. Carbamazepine, valproic acid, phenobarbital, and ethosuximide. Evans W.E., Schentag J.J., Jusko W.J. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring. 3rd Edition:1992;Applied Therapeutics, Vancouver. Chpt. 26, pp. 1-29.
7. El-Nahhas A.S. Physico-chemical characteristics of carbamazepine-β-cyclodextrin inclusion compounds and carbamazepine-PEG solid dispersions. Pharmazie. 51:1996;960-963.
8. Giunchedi P., Conte U., La Manna A. Carbamazepine modified release dosage forms. Drug Dev. Ind. Pharm. 17:1991;1753-1764.
9. Ikinci G., Capan Y., Senel S., Dalkara T., Hincal A.A. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets. Pharmazie. 54:1999;139-141.
10. Qadan A., Süss W. Controlled release of carbamazepine from pellets and tablets manufactured with hydroxypropyl methylcellulose. Pharmazie. 55:2000;628.
11. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 4:1965;117-212.
12. International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Q2B, Validation of analytical procedures. Methodology, 1996 pp. 1-8. Recommended for Adoption at Step 4 of the ICH process on 6 November 1996 by the ICH Steering Committee. Available on the internet at http://www.ich.org/pdfICH/Q2B.pdf on the 21 January 2002.
13. Rustichelli C., Gamberini G., Ferioli V., Gamberini M.C., Ficarra R., Tommasini S. Solid-state study of polymorphic drugs: carbamazepine. J. Pharm. Biomed. Anal. 23:2000;41-54.
14. Wulff M., Aldén M. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci. 8:1999;269-281.
15. Moore J.W., Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996 Jun;64-74.
16. Wan L.S.C., Heng P.W.S., Wong L.F. Relationship between swelling and drug release in a hydrophilic matrix. Drug. Dev. Ind. Pharm. 19:(10):1993;1201-1210.
17. Veiga F., Salsa T., Pina M.E. Influence of technological variables on the release of theophylline from hydrophilic matrix tablets. Drug Dev. Ind. Pharm. 23:(6):1997;547-551.
18. Konrad R., Christ A., Zessin G., Cobet U. The use of ultrasound and penetrometer to characterize the advancement of swelling and eroding fronts in HPMC matrices. Int. J. Pharm. 163:1998;123-131.
19. Bettini R., Catellani P.L., Santi P., Massimo G., Peppas N.A., Colombo P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Controlled Release. 70:2001;383-391.